Lonza Group stock keeps 2026 outlook after Q3 update
Published on 11/02/2026 at 17:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSLonza raises medium-term ambitions
- Lonza kept its full-year outlook after third-quarter performance matched expectations across all business platforms.
- The updated model targets low-teens organic sales growth and a CORE EBITDA margin in the high thirties over the medium term.
- Management also added return-on-invested-capital and free-cash-flow conversion ambitions.
Lonza sharpened its medium-term profitability ambition while keeping its full-year outlook unchanged after the third quarter. The update, announced on October 14, gives investors a higher margin target beyond the current planning horizon.
The Lonza announcement said performance in the third quarter was in line with expectations across all business platforms. The company reiterated its full-year outlook for 11% to 12% constant-currency sales growth and a CORE EBITDA margin of 33% to 34%.
Higher ambition beyond 2026
Lonza now expects organic constant-currency sales growth of 10% to 13% on average over time and aims for a CORE EBITDA margin in the high thirties over the medium term. CORE EBITDA is expected to grow faster than sales.
The company linked the stronger profitability ambition to maturing high-return growth projects, operational and commercial improvements, capital-spending performance and continued overhead discipline. Lonza also added a medium-term return-on-invested-capital ambition of two to three times its weighted average cost of capital and expects free-cash-flow conversion to improve over time.
Foreign exchange remains a near-term variable: Lonza expects currency effects to reduce 2026 sales growth by 2% to 3%. Capsules & Health Ingredients is still expected to deliver mid-single-digit constant-currency growth and further margin expansion for the full year.
The real-time quote of Lonza Group stock traded at 707.00 euros on Lang & Schwarz at 17:46 CET on Monday, November 2, 2026.
Lonza Group at a glance
- Company: Lonza Group
- ISIN: CH0013841017
- Latest quote: 707.00 euros on Lang & Schwarz, November 2, 2026, 17:46 CET
- Full-year sales outlook: 11% to 12% constant-currency growth
- Full-year CORE EBITDA margin outlook: 33% to 34%
- Medium-term CORE EBITDA margin ambition: high thirties
Swiss equities are covered in the current SMI market environment.
